1672-8629
2011 Issue 4
The Adverse Events of Cimetidine and Its Clinical Misdiagnosis
GU Jia-fu;YANG Xiao-feng
GU Jia-fu;YANG Xiao-feng
..............page:248-249
..............page:251-251
The Discussion about Control Measures for the Risk of Using Medicines Which Coming from Hospital Operating Room
LIU Yan-xue;DENG Wei-sheng
LIU Yan-xue;DENG Wei-sheng
..............page:235-236
Pharmaceutical Care on a Patient with G6PD Deficiency Having Acute Hemolytic Syndrome by Postoperative Medication
KUANG Jun-jian
KUANG Jun-jian
..............page:244-246
The Survey of Healthcare Professionals on Cognition Degree for Adverse Drug Reaction in Jiayuguan
HAO Jun-xiang;YAN Shu;LIU Guang-bin;LIU Xiao-shuan;YANG Dong-rui;ZHANG Li;LI Run jun;LIU Hu
HAO Jun-xiang;YAN Shu;LIU Guang-bin;LIU Xiao-shuan;YANG Dong-rui;ZHANG Li;LI Run jun;LIU Hu
..............page:240-243
One Case of Severe Erythra Induced by Tongzhisurunjiang Capsules
Mamat-Aly;Gul-Nar;Tur-Gun
Mamat-Aly;Gul-Nar;Tur-Gun
..............page:251-252
The Review of the Adverse Drug Reaction Using Ibuprofen Suspension
WAN Xue-qin;ZHANG Hua-feng
WAN Xue-qin;ZHANG Hua-feng
..............page:246-247
Guidelines for Good Pharmacoepidemiology Practices
REN Jing-tian;WANG Bo
REN Jing-tian;WANG Bo
..............page:252-256
Experimental Study on the "Dose-Time-Toxicity "Relationship of Acute Hepatotoxicity Induced by Different Components from Polygonum multiflorum in Mice
HUANG Wei;ZHANG Ya-nan;SUN Rong
HUANG Wei;ZHANG Ya-nan;SUN Rong
..............page:193-197
Discussion on the Technical Development of Pediatric Pharmacovigilance
SHEN Lu;DU Xiao-xi
SHEN Lu;DU Xiao-xi
..............page:220-224
Experimental Study on the "Dose-Time-Toxicity" Relationship of Acute Hepatotoxicity Induced by Yangxue Shengfa Capsules to Mice
LI Xiao-yu;SUN Rong;LV Li-li
LI Xiao-yu;SUN Rong;LV Li-li
..............page:204-207
Experimental Study on Mice\'s Acute Toxicity of Yangxue Shengfa Capsules
XIE Yuan-zhang;SUN Rong;ZHANG Ya-nan;QIAN Xiao-lu
XIE Yuan-zhang;SUN Rong;ZHANG Ya-nan;QIAN Xiao-lu
..............page:208-211
Reviewing Drug Safety Risk Management Based on Drug Withdrawl Experiences in USA.
GUO Xiao-xin;DU Xiao-xi;XUE Song-lin
GUO Xiao-xin;DU Xiao-xi;XUE Song-lin
..............page:212-216
..............page:211
Determination of the Contents of 2,3,5,4\'-tetrahydroxystilbene 2-O- β-D-Glucopyranoside,Emodi and Physcion in Yangxue Shengfa Capsules by HPLC
ZHENG Li-na;REN Hai-yong;ZHANG Zuo-ping;SUN Kong
ZHENG Li-na;REN Hai-yong;ZHANG Zuo-ping;SUN Kong
..............page:199-201
Unreasonable Phenomena Excation about Medicine Use Found in the Process of Advisory Service
XU Li-fen
XU Li-fen
..............page:233-235
Discussion on the Situation of Drug Post-marketed Reassessment in China
LI Man;WANG Zhong;ZHANG Xiang-lin
LI Man;WANG Zhong;ZHANG Xiang-lin
..............page:225-228
Investigation and Analysis on Antibacterial Drug Use in Four Cities of China
JING Chun-mei;XIAO Ai-li;Yan Lin;Cheng Gang
JING Chun-mei;XIAO Ai-li;Yan Lin;Cheng Gang
..............page:216-219
..............page:197-198
..............page:229-232
..............page:250-250
Recent Advance on the Association Between HLA-B*1502 Allele and Severe Cutaneous Adverse Reactions in Different Race Induced by Anti-epileptic Drugs
CHENG Xin-min;LI Li;TIAN Yue jie
CHENG Xin-min;LI Li;TIAN Yue jie
..............page:237-239
Pathologic Research on Hepatotoxicity in Mice Caused by Yangxue Shengfa Capsules
LV Li-li;XIE Yuan-zhang;QIAN Xiao-lu;YANG Qian;SUN Rong
LV Li-li;XIE Yuan-zhang;QIAN Xiao-lu;YANG Qian;SUN Rong
..............page:202-204